Professor Seeks FDA Probe Into Stem Cell Cos.' Practices
A University of Minnesota professor urged the U.S. Food and Drug Administration to investigate research firms CellTex Therapeutics Corp. and RNL Bio for their reported practices of treating patients including Texas...To view the full article, register now.
Already a subscriber? Click here to view full article